Factors that predicted CR in all evaluable patients by multivariate analysis
| Variables . | Odds ratio . | P . |
|---|---|---|
| Cytogenetic group | ||
| Favorable | 10.39 | < .0001 |
| Intermediate | 4.67 | < .0001 |
| Myeloperoxidase-positive blast ≥ 50% | 2.64 | < .0001 |
| Induction therapy: IDR arm | 0.97 | .854 |
| Variables . | Odds ratio . | P . |
|---|---|---|
| Cytogenetic group | ||
| Favorable | 10.39 | < .0001 |
| Intermediate | 4.67 | < .0001 |
| Myeloperoxidase-positive blast ≥ 50% | 2.64 | < .0001 |
| Induction therapy: IDR arm | 0.97 | .854 |
CR indicates complete remission; and IDR, idarubicin.